Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.105
-0.005 (-0.16%)
Aug 31, 2026, 12:20 PM EDT - Market open
Altimmune Employees
Altimmune had 57 employees as of December 31, 2025. The number of employees decreased by 2 or -3.39% compared to the previous year.
Employees
57
Change (1Y)
-2
Growth (1Y)
-3.39%
Revenue / Employee
$544
Profits / Employee
-$1,609,825
Market Cap
603.98M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 57 | -2 | -3.39% |
| Dec 31, 2024 | 59 | 0 | - |
| Dec 31, 2023 | 59 | 7 | 13.46% |
| Dec 31, 2022 | 52 | 5 | 10.64% |
| Dec 31, 2021 | 47 | 4 | 9.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Valneva SE | 620 |
| REGENXBIO | 371 |
| Arvinas | 246 |
| ARS Pharmaceuticals | 200 |
| CorMedix | 191 |
| Prime Medicine | 146 |
| AgomAb Therapeutics NV | 62 |
ALT News
- 14 days ago - Altimmune reports Q2 EPS (12c), consensus (12c) - TheFly
- 19 days ago - Altimmune Earnings Call Transcript: Q2 2026 - Transcripts
- 19 days ago - Altimmune Earnings release: Q2 2026 - Filings
- 19 days ago - Altimmune Quarterly report: Q2 2026 - Filings
- 19 days ago - Altimmune Slides: Corporate presentation - Filings
- 19 days ago - Altimmune Announces Second Quarter 2026 Financial Results and Business Update - GlobeNewsWire
- 26 days ago - Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026 - GlobeNewsWire
- 4 weeks ago - Altimmune initiates PERFORMA trial - TheFly